1. Home
  2. CPHI vs SPHL Comparison

CPHI vs SPHL Comparison

Compare CPHI & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPHI
  • SPHL
  • Stock Information
  • Founded
  • CPHI N/A
  • SPHL 2002
  • Country
  • CPHI China
  • SPHL Singapore
  • Employees
  • CPHI N/A
  • SPHL N/A
  • Industry
  • CPHI Biotechnology: Pharmaceutical Preparations
  • SPHL Homebuilding
  • Sector
  • CPHI Health Care
  • SPHL Consumer Discretionary
  • Exchange
  • CPHI Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • CPHI 5.5M
  • SPHL 6.0M
  • IPO Year
  • CPHI N/A
  • SPHL 2024
  • Fundamental
  • Price
  • CPHI $1.89
  • SPHL $0.51
  • Analyst Decision
  • CPHI
  • SPHL
  • Analyst Count
  • CPHI 0
  • SPHL 0
  • Target Price
  • CPHI N/A
  • SPHL N/A
  • AVG Volume (30 Days)
  • CPHI 87.8K
  • SPHL 99.2K
  • Earning Date
  • CPHI 08-13-2025
  • SPHL 02-21-2025
  • Dividend Yield
  • CPHI N/A
  • SPHL N/A
  • EPS Growth
  • CPHI N/A
  • SPHL N/A
  • EPS
  • CPHI N/A
  • SPHL N/A
  • Revenue
  • CPHI $4,295,377.00
  • SPHL $6,456,601.00
  • Revenue This Year
  • CPHI N/A
  • SPHL N/A
  • Revenue Next Year
  • CPHI N/A
  • SPHL N/A
  • P/E Ratio
  • CPHI N/A
  • SPHL N/A
  • Revenue Growth
  • CPHI N/A
  • SPHL N/A
  • 52 Week Low
  • CPHI $1.20
  • SPHL $0.35
  • 52 Week High
  • CPHI $3.35
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • CPHI 55.05
  • SPHL N/A
  • Support Level
  • CPHI $1.70
  • SPHL N/A
  • Resistance Level
  • CPHI $1.93
  • SPHL N/A
  • Average True Range (ATR)
  • CPHI 0.14
  • SPHL 0.00
  • MACD
  • CPHI 0.01
  • SPHL 0.00
  • Stochastic Oscillator
  • CPHI 84.37
  • SPHL 0.00

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: